Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guliz Ozgun

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biomedicines|February 25, 2023
Primary Mediastinal Germ Cell Tumors: A Thorough Literature ReviewGuliz Ozgun, Lucia Nappi
Mediastinum (Hong Kong, China)|December 30, 2022
Genomic features of mediastinal germ cell tumors: a narrative reviewGuliz Ozgun, Craig Nichols, Christian Kollmannsberger, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Bladder Preservation in Muscle-Invasive Bladder Cancer: A Population-Based Analysis from British ColumbiaGuliz Ozgun, Abraham Alexander, Gregory Arbour, et al.
Scientific Reports|April 13, 2024
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinomaMaryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Plos One|May 9, 2025
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumorsArkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon, et al.
The Oncologist|September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell TumorsJack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
JCO Clinical Cancer Informatics|August 25, 2025
Machine Learning Model Integrating Computed Tomography Image-Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular CancerGuliz Ozgun, Neda Abdalvand, Gizem Ozcan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial CancerGillian Vandekerkhove, Andrew J Murtha, David C Müller, et al.
Nature Communications|February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biomedicines|February 25, 2023
Primary Mediastinal Germ Cell Tumors: A Thorough Literature ReviewGuliz Ozgun, Lucia Nappi
Mediastinum (Hong Kong, China)|December 30, 2022
Genomic features of mediastinal germ cell tumors: a narrative reviewGuliz Ozgun, Craig Nichols, Christian Kollmannsberger, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Bladder Preservation in Muscle-Invasive Bladder Cancer: A Population-Based Analysis from British ColumbiaGuliz Ozgun, Abraham Alexander, Gregory Arbour, et al.
Scientific Reports|April 13, 2024
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinomaMaryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Plos One|May 9, 2025
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumorsArkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon, et al.
The Oncologist|September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell TumorsJack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
JCO Clinical Cancer Informatics|August 25, 2025
Machine Learning Model Integrating Computed Tomography Image-Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular CancerGuliz Ozgun, Neda Abdalvand, Gizem Ozcan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial CancerGillian Vandekerkhove, Andrew J Murtha, David C Müller, et al.
Nature Communications|February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Pageof 1